ThinkstockThe world’s second largest maker of laboratory equipment, Thermo Fisher Scientific Inc. (NYSE: TMO) has agree to acquire competitor Life Technologies Corp. (NASDAQ: LIFE) for $13.6 billion in cash ($76 a share). Thermo Fisher…
ThinkstockObesity may be the most closely followed health care issue in the United States. The rate of obesity has increased dramatically in the past two decades, growing from 13% in 1960 to 34% nationally.…
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a minimum overbought.…
ThinkstockAmerica’s least obese cities are Boulder; Charlottesville, Va.; Bellingham Wash.; Fort Collins, Colo.; Naples, Fla.; Denver; San Francisco; San Lois Obisco; Madison, Wisc.; and Colorado Springs. Many of these cities have relatively high income…
Thinkstock24/7 Wall St. recently featured the waves of the most promising turnarounds for 2013. It was amazing to see some of the battered yet recovered stocks on that list. Some of the turnarounds we…
Jon OggInvestors and traders are usually on the hunt for new ideas that will generate positive returns or income. 24/7 Wall St. looks over numerous research calls to find great ideas from value stocks…
ThinkstockPeople who live in nations where most residents were thin, at least as measured against the tremendous number of obese Americans, are getting fatter. Bloomberg blames this, in part, on the number of fast…
Boston Scientific Corp. (NYSE: BSX) is in a long-term turnaround that frankly just feels like it never really has turned around. Or has it? We can criticize the mistakes of management from before the…
ThinkstockMuch of the research coverage on Wall St. from the bulge bracket firms is concentrated on the most liquid, best known stocks from the S&P 500. These names are recognizable to investors and are…
ThinkstockShares of Biogen Idec Inc. (NASDAQ: BIIB) did not just do well on Wednesday. The stock hit an all-time high. News hit late in the day that the U.S. Food and Drug Administration has…
ThinkstockAastrom Biosciences Inc. (NASDAQ: ASTM) has just joined in on the long list of biotech implosions. Perhaps the only thing that is so surprising after the fact, with a 35% price drop now, is…
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is rallying on Wednesday after a report in Seeking Alpha called its Northera, a treatment for symptomatic neurogenic hypotension in Parkinson’s patients, a shoe-in for approval, along with the note…
ThinkstockAccording to the Center for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes and even certain types…
ThinkstockZIOPHARM Oncology Inc. (NASDAQ: ZIOP) is on implosion watch. The small-cap biotech is indicated to be way down on a major disappointment on its Phase 3 trial of palifosfamide for the treatment of metastatic…
ThinkstockSarepta Therapeutics Inc. (NASDAQ: SRPT) should have received a huge boost from “The Barron’s Effect” on Monday. The financial publication, which historically has been referred to as the “Investor’s Weekly Bible Reading,” gave Sarepta a…